{"id":"https://openalex.org/W2585700541","doi":"https://doi.org/10.1021/cen-09604-cover","title":"The year in new drugs","display_name":"The year in new drugs","publication_year":2018,"publication_date":"2018-01-22","ids":{"openalex":"https://openalex.org/W2585700541","doi":"https://doi.org/10.1021/cen-09604-cover","mag":"2585700541"},"language":"en","primary_location":{"id":"doi:10.1021/cen-09604-cover","doi":"https://doi.org/10.1021/cen-09604-cover","is_oa":false,"landing_page_url":"https://doi.org/10.1021/cen-09604-cover","pdf_url":null,"source":{"id":"https://openalex.org/S4210177211","display_name":"C&EN Global Enterprise","issn_l":"2474-7408","issn":["2474-7408"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"C&EN Global Enterprise","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033782239","display_name":"LISA M. JARVIS","orcid":"https://orcid.org/0000-0002-2842-1259","observed_orcids":["https://orcid.org/0000-0002-2842-1259"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lisa M. Jarvis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5033782239"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":5.3301,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.95292794,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"96","issue":"4","first_page":"26","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13656","display_name":"Science, Research, and Medicine","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/new-chemical-entities","display_name":"new chemical entities","score":0.7889999747276306},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.9020000100135803},{"id":"https://openalex.org/keywords/fda-approval","display_name":"FDA approval","score":0.5360000133514404},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.4970000088214874},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.6380000114440918},{"id":"https://openalex.org/keywords/rare-diseases","display_name":"rare diseases","score":0.8489999771118164},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7450000047683716},{"id":"https://openalex.org/keywords/astrazeneca","display_name":"AstraZeneca","score":0.7860000133514404},{"id":"https://openalex.org/keywords/pfizer","display_name":"Pfizer","score":0.7279999852180481},{"id":"https://openalex.org/keywords/asthma-drugs","display_name":"asthma drugs","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3358839750289917}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/cen-09604-cover","doi":"https://doi.org/10.1021/cen-09604-cover","is_oa":false,"landing_page_url":"https://doi.org/10.1021/cen-09604-cover","pdf_url":null,"source":{"id":"https://openalex.org/S4210177211","display_name":"C&EN Global Enterprise","issn_l":"2474-7408","issn":["2474-7408"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"C&EN Global Enterprise","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2795399155","https://openalex.org/W2916110604","https://openalex.org/W2807291638","https://openalex.org/W2782981769","https://openalex.org/W2916979802","https://openalex.org/W2465721199","https://openalex.org/W4213267099","https://openalex.org/W790273468","https://openalex.org/W4240339632","https://openalex.org/W4311560558"],"abstract_inverted_index":{"After":[0],"a":[1,7,43,75,113,123],"dip":[2],"in":[3,10,66,96,110,115,131,139],"2016,":[4],"2017":[5,121],"brought":[6],"two-decade":[8],"peak":[9],"drug":[11],"approvals.":[12],"The":[13,100],"U.S.":[14],"Food":[15],"&":[16],"Drug":[17],"Administration":[18],"gave":[19],"its":[20,86,140],"green":[21],"light":[22],"to":[23,41,57,88],"46":[24],"new":[25,79,91,137],"molecular":[26],"entities,":[27],"the":[28,71],"highest":[29],"number":[30],"since":[31],"1996.":[32],"Cancer":[33],"treatments":[34,144],"and":[35,48,145],"drugs":[36],"for":[37,60,119,126],"rare":[38],"diseases":[39],"continued":[40],"command":[42],"hefty":[44],"portion":[45],"of":[46,78,98,112],"approvals,":[47],"many":[49,90,106],"benefited":[50],"from":[51],"an":[52,146],"agency":[53],"that":[54],"seems":[55],"motivated":[56],"streamline":[58],"development":[59],"truly":[61],"innovative":[62],"medicines.":[63,80],"Early":[64],"on":[65],"2017,":[67],"it":[68],"was":[69,122],"clear":[70],"year":[72],"would":[73],"bring":[74],"bountiful":[76],"crop":[77],"By":[81],"mid-June,":[82],"FDA":[83],"had":[84,128],"given":[85],"nod":[87],"as":[89,93],"molecules":[92],"were":[94,109],"approved":[95],"all":[97],"2016.":[99,132],"prior":[101],"year\u2019s":[102],"meager":[103],"output":[104],"meant":[105],"big":[107],"companies":[108],"need":[111],"rebound":[114],"productivity.":[116],"And":[117],"indeed,":[118],"some,":[120],"salve.":[124],"AstraZeneca,":[125],"example,":[127],"no":[129],"approvals":[130],"It":[133],"now":[134],"has":[135],"three":[136],"products":[138],"portfolio:":[141],"two":[142],"cancer":[143],"asthma":[147],"drug.":[148],"Pfizer,":[149]},"counts_by_year":[{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2017-02-10T00:00:00"}